Investigation of family health in cancer patients and their caregivers
A Multi-center Investigation of Family Health, Needs, Perceived Support, Self-efficacy and Quality of Life During the Cancer Trajectory: A Longitudinal Mixed Methods Study Among Danish Cancer Patients and Their Caregivers
This study looks at how cancer affects the health and well-being of patients with breast, prostate, colorectal cancers, and blood cancers, along with their caregivers, to see what support they need during treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 240 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense C) |
| Trial ID | NCT06433349 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the health and well-being of families affected by cancer, focusing on patients with breast, prostate, colorectal cancers, and hematologic neoplasms, along with their caregivers. It will assess factors such as quality of life, self-efficacy, depression, stress, and resilience throughout the cancer treatment and survivorship journey. By conducting surveys and interviews, the study seeks to identify vulnerable families and understand the support they need during this challenging time.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 diagnosed with breast, prostate, colorectal cancer, or lymphoma, along with their designated caregivers.
Not a fit: Patients who cannot understand or provide informed consent, or who do not speak Danish, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of family dynamics in cancer care, leading to improved support systems for both patients and their families.
How similar studies have performed: While there is a growing recognition of the importance of family involvement in cancer care, this specific approach to studying family health in the context of cancer treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * curative intended patients and their eventual appointed caregivers \>18 * breast-, prostate- colorectal cancer or lymphoma. Exclusion Criteria: * Not able to understand or give written informed consent * Not able to speak Danish or complete questionnaires in Danish
Where this trial is running
Odense C
- Odense University Hospital — Odense C, Denmark (Recruiting)
Study contacts
- Study coordinator: Lærke K. Tolstrup, PhD
- Email: laerke.tolstrup@rsyd.dk
- Phone: +4540295129
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.